Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

the Mechanism of the Downregulation of R-spondin3 in Sepsis Induced Lung Injury

NCT04546919 is registered in ClinicalTrials.gov with Xinhua Hospital, Shanghai Jiao Tong University School of Medicine as lead sponsor.

NCT NCT04546919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04546919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
the Mechanism of the Downregulation of R-spondin3 in Sepsis Induced Lung Injury
Lead sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase
Observational
Overall status
Unknown status
Start date
July 8, 2020
Completion date
December 12, 2021
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lung injury (ali), acute respiratory distress syndrome (ards)